Large-population passages of vesicular stomatitis virus in interferon- treated cells select variants of only limited resistance

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 6414-6417

  Novella, Isabel S ^a   Cilnis, Martin ^a   Elena, Santiago F ^b,d   Kohn, Joshua ^a   Moya, Andres ^b   Domingo, Esteban ^c   Holland, John J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; ARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0029791835     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.6414-6417.1996     Document Type: Article

References (60)

1. Akkaraju, G. R., P. Whitaker-Dowling, J. S. Youngner, and R. Jagus. 1989. Vaccinia specific kinase inhibitory factor prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate. J. Biol. Chem. 264: 10321-10325.
2. Alcami, A., and G. L. Smith. 1995. Cytokine receptors encoded by poxviruses: a lesson in cytokine biology, Immunol. Today 16:474-478.
3. Beattie, E., K. L. Denzler, J. Tartaglia, M. E. Perkus, E. Paoletti, and B. L. Jacobs. 1995. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:499-505.
4. Carrigan, D. R., and C. M. Kabacoff. 1987. Identification of a nonproductive cell-associated form of measles virus by its resistance to inhibition by recombinant human interferon. J. Virol. 61:1919-1926.
5. Carrigan, D. R., and K. K. Knox. 1990. Identification of interferon-resistant subpopulations in several strains of measles virus: positive selection by growth of the virus in brain tissue. J. Virol. 64:1606-1615.
6. Cattaneo, R., and M. Billeter. 1992. Mutations and A/I hypermutations in measles virus persistent infections. Curr. Top. Microbiol. Immunol. 176:63-74.
7. Cayley, P. L., J. A. Davies, K. G. McCullagh, and I. M. Kerr. 1984. Activation of the pp(A2′)nA system in interferon-treated herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′)n-AA-dependent RNase. Eur. J. Biochem. 143:165-174.
8. Clarke, D. K., E. A. Duarte, S. Elena, A. Moya, E. Domingo, and J. Holland. 1994. The red queen reigns in the kingdom of RNA viruses Proc. Natl. Acad. Sci. USA 91:4821-4824.
9. Clarke, D. K., E. A. Duarte, A. Moya, S. F. Elena, E. Domingo, and J. Holland. 1993. Genetic bottlenecks and population passages cause profound fitness differences in RNA viruses. J. Virol. 67:222-228.
10. Coffin, J. M. 1990. Genetic variation in retroviruses. Appl. Virol. Res. 2:11-33.
11. Coffin, J. M. 1992. Genetic diversity and evolution of retrovirus. Curr. Top. Microbiol. Immunol. 176:143-164.
12. Davies, M. V., O. Elroy-Stein, R Jagus, B. Moss, and R. J. Kaufman. 1992. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66:1943-1950.
13. DiBisceglie, A. M., P. Martin, C. Kassianides. M. Lisker-Melamn, L. Murray, J. Waggoner, Z. Goodman, S. M. Banks, and J. H. Hoofnagle. 1989. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 321:1506-1510.
14. Domingo, E. 1989. RNA virus evolution and the control of viral disease. Prog. Drug Res. 33:93-133.
15. Domingo, E., and J. J. Holland. 1992. Complications of RNA heterogeneity for the engineering of virus vaccines and antiviral agents, p. 13-31. In J. K. Setlow (ed.), Genetic engineering, principles and methods. Plenum Press, New York.
16. Domingo, E., and J. J. Holland. 1994. Mutation rates and rapid evolution of RNA viruses, p. 161-183. In S. Morse (ed.), The evolutionary biology of viruses. Raven Press, New York.
17. Drake, J. W. 1993. Rates of spontaneous mutations among RNA viruses. Proc. Natl. Acad. Sci. USA 90:4171-4175.
18. Duarte, E., D. Clarke, A. Moya, E. Domingo, and J. Holland. 1992. Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet. Proc. Natl. Acad. Sci. USA 89:6015-6019.
19. Duarte, E. A., D. C. Clarke, A. Moya, S. F. Elena, E. Domingo, and J. Holland. 1993. Many-trillionfold amplification of single RNA virus particles fails to overcome the Müller's ratchet effect. J. Virol. 67:3620-3623.
20. Duarte, E. A., I. S. Novella, S. Ledesma, D. C. Clarke, A. Moya, S. F. Elena, E. Domingo, and J. J. Holland. 1994. The subclonal components of consensus fitness in an RNA virus clone. J. Virol. 68:4295-4301.
21. Enomoto, N., M. Kurosaki, Y. Tanaka, F. Marumo, and C. Sato. 1994. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J. Gen. Virol. 75:1361-1369.
22. Esleban, M., J. Benavente, and E. Paez. 1986. Mode of sensitivity and resistance of vaccinia virus replication to interferon. J. Gen. Virol. 67:801-808.
23. Gil, B., C. Qian, J. I. Riezu-Boj, M. P. Civeira, and J. Prieto. 1993. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology 18:1050-1054.
24. Gunnery, S., A. P. Rice, H. D. Robertson, and M. B. Mathews. 1990. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 87:8687-8691.
25. Gutterman, J. U. 1994. Cytokine therapeutics: lessons from interferon α. Proc. Natl. Acad. Sci. USA 91:1198-1205.
26. Holland, J. J. 1992. Genetic diversity of RNA viruses. Springer-Verlag, Berlin.
27. Holland, J. J., J. C. de la Torre, D. K. Clarke, and E. Duarte. 1991. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J. Virol. 65:2960-2967.
28. Holland, J. J., J. C. de la Torre, and D. Steinhauer. 1992. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:1-20.
29. Holland, J. J., K. Spindler, F. Horodyski, E. Grabau, S. Nichol, and S. VandePol. 1982. Rapid evolution of RNA genomes. Science 215:1577-1585.
30. Imani, F., and B. L. Jacobs. 1988. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 σ3 protein. Proc. Natl. Acad. Sci. USA 85:7887-7891.
31. Karupiah, G., T. N. Fredrickson, K. L. Holmes, L. H. Khairallah, and R. M. L. Buller. 1993. Importance of interferons in recovery from mousepox. J. Virol. 67:4214-4226.
32. Katze, M. G., B. M. Detjen. B. Safer, and R. M. Krug. 1986. Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol. Cell. Biol. 6:1741-1750.
33. Kerr, I. M., and G. R. Stark. 1992. The antiviral effects of interferon and their inhibition. J. Interferon Res. 12:237-240.
34. Kitajewski, J., R. J. Schneider, B. Safer, S. M. Munemitsu, C. E. Samuel, B. Thimmappaya, and T. Shenk. 1986. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α protein kinase. Cell 45:195-200.
35. Koziel, M. J., and B. D. Walker. 1992. Viruses, chemotherapy and immunity. Parasitology 105:s85-s92.
36. Kunzi, M. S., H. Farzadegan, J. B. Margolock, D. Vlahov, and P. M. Pitha. 1995. Identification of human immunodeficiency virus primary isolates resistant to interferon α and correlation to prevalence to disease progression. J. Infect. Dis. 171:822-328.
37. Lane, H. C., J. Feinberg, V. Davey, L. Deyton, M. Baseler, J. Manischewitz, H. Masur, J. A. Kovacs, B. Herpin, R. Walker, J. A. Metcalf, N. Salzman, G. Quinnan, and A. S. Fauci. 1988. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma. Lancet ii:1218-1222.
38. Lee, T. G., J. Tomita, A. G. Hovanessian, and M. G. Katze. 1990. Purification and partial characterization of a cellular inhibitor of interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc. Natl. Acad. Sci. USA 87:6208-6212.
39. Lewontin, R. C. 1974. The genetic basis of evolutionary change. Columbia University Press, New York.
40. Marcus, P. I., P. T. Guidon, Jr., and M. J. Sekellick. 1981. Interferon induction by viruses. VII. Mengovirus: "interferon sensitive" mutant phenotype attributed to interferon-inducing particle activity. J. Interferon Res. 1:601-611.
41. Marcus, P. I., and M. J. Sekellick. 1985. Interferon induction by viruses. XII. Detection and assay of interferon induction-suppressing particles of vesicular stomatitis virus. Virology 142:411-415.
42. Marcus, P. I., and M. J. Sekellick. 1987. Interferon induction by viruses. XV. Biological characteristics of interferon induction-supressing particles of vesicular stomatitis virus. J. Interferon Res. 7:269-284.
43. Marcus, P. I., M. J. Sekellick, and S. T. Nichol. 1992. Interferon induction by viruses. XXI. Vesicular stomatitis virus: interferon inducibility as a phylogenetic marker. J. Interferon Res. 12:297-305.
44. Mellits, K. H., M. Kostura, and M. B. Mathews. 1990. Interaction of adenovirus VA RNA1 with the protein kinase DAI: nonequivalence of binding and function. Cell 61:843-852.
45. Moskophidis, D., M. Battegay, M. A. Bruendler, E. Laine, I. Gresser, and R M. Zinkernagel. 1994. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J. Virol. 68:1951-1955.
46. Naoumov, N. V., M. G. Thomas, A. L. Mason, S. Chokshi, C. J. Bodicky, F. Farzaneh, R. Williams, and R. P. Perrillo. 1995. Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment. Gastroenterology 108:505-514.
47. Novella, I. S., E. A. Duarte, S. F. Elena, A. Moya, E. Domingo, and J. J. Holland. 1995. Exponential increases of RNA virus fitness during large population transmissions. Proc. Natl. Acad. Sci. USA 92:5841-5844.
48. Patterson, J. B., and C. E. Samuel. 1995. Expression and regulation by interferon of a double-stranded RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 15:5376-5388.
49. Riviere, Y., I. Gresser, J. C. Guillon, and M. G. Tovey. 1977. Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc. Natl. Acad. Sci. USA 74:2135-2139.
50. Roy, S., M. G. Katze, N. T. Parkin, I. Edery, A. G. Hovanessian, and N. Sanenberg. 1990. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216-1219.
51. Saitoh, H., S. Naitoh, H. Okamoto, and Y. Akahane. 1994. Prompt decrease of circulating hepatitis C virus in patients with chronic hepatitis C after treatment with interferon. J. Interferon Res. 14:239-244.
52. Samuel, C. E. 1991. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprising selective antiviral activities. Virology 183:1-11.
53. Sekellick, M. J., and P. I. Marcus. 1989. Interferon induction by viruses. XVII. Non-temperature-sensitive mutations regulate interferon induction by vesicular stomatitis virus. J. Gen. Virol. 70:405-415.
54. Smith, D. B., and S. C. Inglis. 1987. The mutation rate and variability of eukaryotic viruses: an analytical review. J. Gen. Virol. 68:2729-2740.
55. Sokal, R. R., and F. J. Rohlf. 1981. Biometry. Freeman, New York.
56. Vilcek, J., and G. C. Sen. 1996. Interferons and other cytokines, p. 375-399. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia.
57. Wain-Hobson, S. 1992. Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. Curr. Top. Microbiol. Immunol. 176:181-194.
58. Whitaker-Dowling, P., and J. S. Youngner. 1984. Characterization of a specific kinase factor produced by vaccinia virus which inhibits the interferon-induced protein kinase. Virology 137:171-181.
59. Whitaker-Dowling, P. A., D. K. Wilcox, C. C. Widnell, and J. S. Youngner. 1983. Interferon-mediated inhibition of virus penetration. Proc. Natl. Acad. Sci. USA 80:1083-1086.
60. Youngner, J. S., and G. Wertz. 1968. Interferon induction in mice by vesicular stomatitis virus. J Virol. 2:1360-1361.